We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+3.78%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$274M
AUM Growth
-$6.67M
Cap. Flow
-$848K
Cap. Flow %
-0.31%
Top 10 Hldgs %
29.37%
Holding
164
New
33
Increased
27
Reduced
41
Closed
27

Top Buys

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$4.22M
2
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$4.16M
3
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$4.05M
4
CRM icon
Salesforce
CRM
+$2.28M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.1M

Top Sells

Rank Stock Value
1
SP
SP Plus Corporation
SP
+$4.12M
2
OFIX icon
Orthofix Medical
OFIX
+$2.44M
3
IDYA icon
IDEAYA Biosciences
IDYA
+$2.31M
4
IMCR icon
Immunocore
IMCR
+$2.26M
5
NUVL
Nuvalent
NUVL
+$2.23M

Sector Composition

Rank Sector Weight
1 Healthcare 43.71%
2 Technology 17%
3 Consumer Discretionary 6.54%
4 Energy 4.11%
5 Consumer Staples 3.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EDU icon
126
New Oriental
EDU
$9.24B
$358K 0.13%
4,600
-100
-2% -$8.15K
CLDX icon
127
Celldex Therapeutics
CLDX
$3.37B
$356K 0.13%
+9,627
New +$363K
KURA icon
128
Kura Oncology
KURA
$874M
$345K 0.13%
+16,764
New +$345K
PDD icon
129
Pinduoduo
PDD
$132B
$343K 0.13%
2,578
-4,678
-64% -$633K
BEKE icon
130
KE Holdings
BEKE
$19.5B
$335K 0.12%
23,707
-19,100
-45% -$299K
VERA icon
131
Vera Therapeutics
VERA
$2.27B
$331K 0.12%
+9,162
New +$363K
FDMT icon
132
4D Molecular Therapeutics
FDMT
$582M
$326K 0.12%
15,532
– –
TAL icon
133
TAL Education Group
TAL
$6.93B
$319K 0.12%
29,900
-3,900
-12% -$46.1K
PHVS icon
134
Pharvaris
PHVS
$2.43B
$315K 0.12%
16,750
– –
APLS
135
DELISTED
Apellis Pharmaceuticals
APLS
$290K 0.11%
7,566
+300
+4% +$13.6K
TYRA icon
136
Tyra Biosciences
TYRA
$1.57B
$257K 0.09%
+16,078
New +$277K
CABA icon
137
Cabaletta Bio
CABA
$457M
$166K 0.06%
22,208
– –
BASE
138
DELISTED
Couchbase
BASE
– –
-13,756
Closed -$362K
COIN icon
139
Coinbase
COIN
$39.2B
– –
-3,761
Closed -$997K
CPT icon
140
Camden Property Trust
CPT
$11B
– –
-14,100
Closed -$1.39M
FCNCA icon
141
First Citizens BancShares
FCNCA
$25.2B
– –
-661
Closed -$1.08M
GE icon
142
GE Aerospace
GE
$380B
– –
-15,814
Closed -$1.77M
IMCR icon
143
Immunocore
IMCR
$1.73B
– –
-34,762
Closed -$2.26M
IMRX icon
144
Immuneering
IMRX
$293M
– –
-254,513
Closed -$736K
KRYS icon
145
Krystal Biotech
KRYS
$9.81B
– –
-3,923
Closed -$698K
LAD icon
146
Lithia Motors
LAD
$8.35B
– –
-6,401
Closed -$1.93M
LEGN icon
147
Legend Biotech
LEGN
$4B
– –
-36,385
Closed -$2.04M
LI icon
148
Li Auto
LI
$12.6B
– –
-13,066
Closed -$396K
MA icon
149
Mastercard
MA
$493B
– –
-2,547
Closed -$1.23M
MRSN
150
DELISTED
Mersana Therapeutics
MRSN
– –
-4,893
Closed -$548K
3 4 5
6
7

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
VIA
Virtus Investment Advisers Hartford, Connecticut $363M AUM 34.89% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

HighVista Strategies's Q2 2024 Portfolio in Review

As of Q2 2024, HighVista Strategies held 164 positions worth $274M, down 2.4% from $280M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

HighVista Strategies's Q2 2024 filing shows 33 new, 27 increased, 41 reduced and 27 closed positions. Its largest new stake was CATALENT, INC.: 75,600 shares worth $4.25M. The largest sale was SP Plus Corporation, an estimated $4.12M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 45% a quarter earlier, followed by Technology and Consumer Discretionary.

  • HighVista Strategies's largest Q2 2024 buy was CATALENT, INC.: 75,600 shares worth $4.25M.
  • HighVista Strategies added most to Salesforce in Q2 2024, an estimated $2.28M increase.
  • HighVista Strategies's biggest Q2 2024 reduction was IDEAYA Biosciences, cutting an estimated $2.31M.
  • HighVista Strategies fully exited SP Plus Corporation in Q2 2024, selling an estimated $4.12M.
  • HighVista Strategies's ten largest holdings make up 29% of its $274M portfolio in Q2 2024.
  • HighVista Strategies opened 33 new positions and closed 27 in Q2 2024.
  • HighVista Strategies's portfolio value fell 2.4% quarter-over-quarter to $274M.

Based on HighVista Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.